Widaplik Tablet
Product Images NDC 24338-003

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Widaplik (NDC 24338-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Telmisartan-structure (Telmisartan Structure)

Chemical structure of the active ingredient telmisartan, showing its molecular framework with multiple aromatic rings and functional groups.*

FDA Label Image

Amlodipine Structure (Amlodipine Structure)

Chemical structure diagram showing molecular formulas, including a chlorinated aromatic ring and sulfonyl group, likely representing an active ingredient or related compound. No specific ingredient name is labeled in the image.*

FDA Label Image

Indapamide Structure (Indapamide Structure)

Chemical structure of telmisartan, amlodipine, and indapamide in the WIDAPLIK product, showing molecular connections and functional groups including aromatic rings, a sulfonamide group, chlorine, and methyl substitutions consistent with the active ingredients.*

FDA Label Image

10mg-rev02 (Widaplik 10mg Rev02 Label)

FDA Label Image

20mg-label (Widaplik 20mg Rev02 Label)

FDA Label Image

40mg-rev02 (Widaplik 40mg Rev02 Label)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.